Karyopharm Therapeutics Inc (KPTI)
1.085
+0.02
(+2.36%)
USD |
NASDAQ |
May 10, 13:04
Karyopharm Therapeutics Price: 1.085 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 09, 2024 | 1.04 | 1.11 | 1.00 | 1.06 | 1.453M |
| May 08, 2024 | 1.13 | 1.20 | 1.02 | 1.02 | 2.639M |
| May 07, 2024 | 1.17 | 1.200 | 1.09 | 1.10 | 990027.0 |
| May 06, 2024 | 1.13 | 1.19 | 1.11 | 1.15 | 848584.0 |
| May 03, 2024 | 1.11 | 1.185 | 1.08 | 1.13 | 983372.0 |
| May 02, 2024 | 1.10 | 1.13 | 1.045 | 1.08 | 975016.0 |
| May 01, 2024 | 1.06 | 1.15 | 1.055 | 1.08 | 1.558M |
| Apr 30, 2024 | 1.10 | 1.135 | 1.02 | 1.03 | 1.165M |
| Apr 29, 2024 | 1.06 | 1.17 | 1.06 | 1.10 | 1.012M |
| Apr 26, 2024 | 1.05 | 1.08 | 1.02 | 1.06 | 660736.0 |
| Apr 25, 2024 | 1.07 | 1.10 | 1.03 | 1.06 | 644718.0 |
| Apr 24, 2024 | 1.10 | 1.15 | 1.05 | 1.09 | 1.204M |
| Apr 23, 2024 | 1.12 | 1.17 | 1.08 | 1.09 | 1.591M |
| Apr 22, 2024 | 1.17 | 1.20 | 1.12 | 1.13 | 791015.0 |
| Apr 19, 2024 | 1.26 | 1.305 | 1.13 | 1.17 | 1.442M |
| Apr 18, 2024 | 1.42 | 1.42 | 1.22 | 1.28 | 1.306M |
| Apr 17, 2024 | 1.19 | 1.38 | 1.14 | 1.38 | 3.176M |
| Apr 16, 2024 | 1.14 | 1.20 | 1.03 | 1.10 | 1.171M |
| Apr 15, 2024 | 1.22 | 1.225 | 1.14 | 1.155 | 810682.0 |
| Apr 12, 2024 | 1.34 | 1.345 | 1.18 | 1.22 | 1.392M |
| Apr 11, 2024 | 1.28 | 1.34 | 1.26 | 1.34 | 680488.0 |
| Apr 10, 2024 | 1.31 | 1.340 | 1.25 | 1.27 | 988363.0 |
| Apr 09, 2024 | 1.33 | 1.415 | 1.31 | 1.34 | 709129.0 |
| Apr 08, 2024 | 1.38 | 1.39 | 1.29 | 1.35 | 808885.0 |
| Apr 05, 2024 | 1.31 | 1.41 | 1.280 | 1.36 | 751476.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6758
Minimum
Nov 29 2023
27.72
Maximum
Mar 02 2020
8.407
Average
6.545
Median
Price Benchmarks
| Geron Corp | 3.80 |
| Arbutus Biopharma Corp | 2.845 |
| Verastem Inc | 11.89 |
| Actinium Pharmaceuticals Inc | 8.70 |
| Chimerix Inc | 0.973 |
Price Related Metrics
| PS Ratio | 0.8487 |
| Earnings Yield | -115.2% |
| Market Cap | 124.85M |